ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma prnasia
September 30, 2020The National Comprehensive Cancer Network? (NCCN?) announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) for Pediatric Hodgkin Lymphoma. -
EC expands Takeda’s Adcetris authorisation for Hodgkin lymphoma pharmaceutical-technology
February 14, 2019The European Commission (EC) has expanded the marketing authorisation of Takeda Pharmaceutical’s Adcetris (brentuximab vedotin) to adults with previously untreated CD30+ Stage IV Hodgkin lymphoma.... -
NICE recommends against Opdivo for classical Hodgkin lymphoma
pharmafile
March 16, 2017The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab)... -
Hodgkin Lymphoma Survivors Face Risk of Second Cancer: Study
drugs.com
March 14, 2017The risk of developing a second type of cancer may be high among Hodgkin lymphoma survivors, especially those with a family history of cancer.
Pharma Sources Insight January 2025
